-
ATOS Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Atossa Therapeutics (ATOS)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 74.88 mm | 74.88 mm | 74.88 mm | 74.88 mm | 74.88 mm | 74.88 mm |
Cash burn (monthly) | 1.59 mm | 1.61 mm | 2.41 mm | 2.53 mm | 1.58 mm | 1.63 mm |
Cash used (since last report) | 8.06 mm | 8.16 mm | 12.25 mm | 12.85 mm | 8.05 mm | 8.28 mm |
Cash remaining | 66.81 mm | 66.72 mm | 62.63 mm | 62.03 mm | 66.83 mm | 66.60 mm |
Runway (months of cash) | 42.1 | 41.6 | 26.0 | 24.5 | 42.2 | 40.9 |
13F holders | Current |
---|---|
Total holders | 88 |
Opened positions | 16 |
Closed positions | 8 |
Increased positions | 20 |
Reduced positions | 24 |
13F shares | Current |
---|---|
Total value | 40.95 bn |
Total shares | 37.36 mm |
Total puts | 91.80 k |
Total calls | 465.80 k |
Total put/call ratio | 0.2 |
Largest owners | Shares | Value |
---|---|---|
BlackRock | 9.67 mm | $14.69 bn |
CVI Investments | 7.76 mm | $0.00 |
Vanguard | 6.60 mm | $10.03 bn |
Geode Capital Management | 2.81 mm | $4.28 bn |
Intracoastal Capital | 2.25 mm | $1.94 mm |
STT State Street | 1.73 mm | $2.63 bn |
Renaissance Technologies | 1.31 mm | $1.99 bn |
NTRS Northern Trust | 954.20 k | $1.45 bn |
MS Morgan Stanley | 457.52 k | $695.43 mm |
Charles Schwab Investment Management | 347.61 k | $528.37 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
27 Jun 24 | Jonathan Finn | Stock Option Common Stock | Grant | Acquire A | No | No | 1.05 | 125,000 | 131.25 k | 125,000 |
27 Jun 24 | Tessa Cigler | Stock Option Common Stock | Grant | Acquire A | No | No | 1.05 | 125,000 | 131.25 k | 125,000 |
27 Jun 24 | Richard I Steinhart | Stock Option Common Stock | Grant | Acquire A | No | No | 1.05 | 125,000 | 131.25 k | 125,000 |
27 Jun 24 | Chen Shu-Chih | Stock Option Common Stock | Grant | Acquire A | No | No | 1.05 | 125,000 | 131.25 k | 125,000 |
27 Jun 24 | Remmel H. Lawrence | Stock Option Common Stock | Grant | Acquire A | No | No | 1.05 | 125,000 | 131.25 k | 125,000 |